INCOG BioPharma positions itself as a leading Contract Development and Manufacturing Organization (CDMO) focused on enhancing the development and commercialization of injectable drug products. The company emphasizes its commitment to delivering better solutions through a consultative approach that prioritizes the unique needs of its clients. With state-of-the-art facilities and advanced equipment, INCOG BioPharma aims to streamline the drug development journey, ensuring that every decision made is aligned with the success of the client's project. Their experienced team leverages decades of industry knowledge to provide a reliable partnership that emphasizes timely and budget-conscious outcomes.

The company has made significant investments in its infrastructure, including the installation of cleanrooms and a dedicated analytical and quality control testing laboratory. These advancements are designed to support the manufacturing of injectable drug products while maintaining high standards of quality and safety. INCOG BioPharma's focus on innovation and growth is evident in its expansion plans, which include increasing production capacity to meet the rising demand in the biopharmaceutical sector. By fostering a fulfilling workplace that encourages creativity and collaboration, INCOG BioPharma aims to make a meaningful impact on the lives of patients through the development of life-saving medications.

United States

INCOG BioPharma Services is a CDMO with an unparalleled client-centric approach supporting biopharmaceutical partners' clinical and commercial requirements. The company has built a state-of-the-art facility with 90,000 square feet to support biopharmaceutical companies. INCOG BioPharma Services also added 100 million units of syringe/cartridge capacity and announced a collaboration with Resilience to expedite manufacturing of biological drug substance and drug product.

INCOG BioPharma

Company Details